Harbourvest Partners’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-56,979
| Closed | -$1.28M | – | 63 |
|
|
2023
Q2 | $1.28M | Sell |
56,979
-1
| -0% | -$23 | 0.36% | 34 |
|
|
2023
Q1 | $689K | Hold |
56,980
| – | – | 0.23% | 40 |
|
|
2022
Q4 | $259K | Hold |
56,980
| – | – | 0.09% | 49 |
|
|
2022
Q3 | $374K | Hold |
56,980
| – | – | 0.12% | 51 |
|
|
2022
Q2 | $615K | Hold |
56,980
| – | – | 0.2% | 43 |
|
|
2022
Q1 | $1.09M | Hold |
56,980
| – | – | 0.22% | 44 |
|
|
2021
Q4 | $2.04M | Hold |
56,980
| – | – | 0.26% | 33 |
|
|
2021
Q3 | $4.19M | Hold |
56,980
| – | – | 0.39% | 20 |
|
|
2021
Q2 | $7.95M | Hold |
56,980
| – | – | 0.76% | 15 |
|
|
2021
Q1 | $16.6M | Hold |
56,980
| – | – | 2.22% | 6 |
|
|
2020
Q4 | $35.6M | Buy |
+56,980
| New | +$35.6M | 13.9% | 3 |
|